Skip to main content
. 2018 Mar 7;8(8):2094–2106. doi: 10.7150/thno.22069

Figure 5.

Figure 5

F56-CM inhibits tumor growth in xenograft mice models. (A) Schema for subcutaneous implantation of BGC-823 or HT-29 cells into the nude mice on day 0 and therapeutic injection of indicated drugs on day 7. The mice were sacrificed on day 28. Tumor nodules, tumor weights and tumor growth curves of BALB/c nu/nu mice bearing BGC-823 gastric cancer cells (B) and HT-29 colon cancer cells (C) are shown. Data represent mean ± SD (n = 6). *P < 0.05; **P < 0.01; *** P < 0.001; n.s., no significance.